Alopecia Drugs Market Poised to Grow at a CAGR of 7.2% by 2024

Alopecia Drugs Market Poised to Grow at a CAGR of 7.2% by 2024


Infinium Global Research has added a new report on Alopecia Drugs Market. The report presents analysis of global as well as regional markets of alopecia drugs market over the period of 2016 to 2024. Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the global alopecia drugs market but also make strategic decisions to capture the most lucrative markets in the near future. The market size is presented in terms of value for the historic year 2016 and estimated for forecast period of 2018-2024.

 

Alopecia is a Latin word that refers to hair loss and scientifically, it is known as Androgenic Alopecia. This is a genetic hair loss condition that occurs in both male and female as pattern baldness and pattern hair loss. Globally, numerous people are suffering from the hair losses. The most common types of alopecia include alopecia areata, alopecia totalis, alopecia universalis and so on. Mainly, alopecia is a genetic condition but it can also occur due to the fungal infection, serious health problem and unhealthy conditions of scalp. The alopecia drugs are used to treat the diverse conditions of hair loss.

 

The genetics is one of the major factor driving the growth of alopecia drugs market across the globe. The rising prevalence of cancer and its treatment methods such as chemotherapy, leads to heavy hair loss that results into the increase demand of hair loss therapies. In addition, the rising acceptance of alopecia drug across the world, rapidly changing lifestyle leading to physical inactivity and increase work stress among employees can results in hair falls. Factors such as less side effects of alopecia drugs, and enhanced effectiveness for treatments are some factors that contribute to the growth of alopecia market.

 

However, a high cost of medication is hampering the growth of alopecia drug market.Moreover, ongoing research and developments by the healthcare expertise to increase the performance and efficiency of drug is projected to create more opportunities in upcoming years.

North America is expected to dominate the market of alopecia drug over the forecast period of 2018 to 2024. The North America government supports and favors innovation of new drugs, The hectic lifestyle of population results in rise in occurrence of hair fall cases which is expected to escalate the market growth of alopecia drugs in the North America region. In addition, the Asia-pacific region is expected to grow at the fastest CAGR in the alopecia drugs market due to the increasing population and rising healthcare expenditures for new innovative treatments

 

Get 15% discount for early purchase of global alopecia drugs market report by clicking the following link, Use code IGRD15 to request the discount in the given form

https://www.infiniumglobalresearch.com/reports/request-discount/1330

 

The recent report identified that dominated the global alopecia drugs market over the last couple of years, while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the alopecia drugs market worldwide.

 

The report segments the global alopecia drugs market on the basis of Alopecia Types, Route of administration (ROA) and Gender.

 

Global Alopecia Drugs Market by Alopecia Types

·         Alopecia Areata

·         Alopecia Totalis

·         Alopecia Universalis

·         Others

 

Global Alopecia Drugs Market by Route of Administration (ROA)

·         Oral

·         Topical

·         Injectable

 

Global Alopecia Drugs Market by Gender

·         Men

·         Women

 

Companies Profiled in the Report

·         GlaxoSmithKline

·         Johnson & Johnson

·         Cipla Inc.

·         Dr. Reddy’s Laboratories Ltd

·         Merck

·         Aqua Pharmaceuticals

·         Bayer HealthCare

·         AndroScience

·         Helix BioMedix

·         The Himalaya Drug Company

·         others

 

About Infinium Global Research

Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.

Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.


© 2024. Infinium Global Research LLP. All Rights Reserved.